title: Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome.
abstract: The chronic state of hypovolemia, hypotension, and hypokalemia found in Bartter's syndrome has been shown to lead to a chronic nephropathy, which then can progress toward end-stage renal disease and dialysis. This progression, however, has never been reported for Gitelman's syndrome, a variant of Bartter's syndrome that shows a milder clinical picture. This report is the first to document this progression (ie, the development of end-stage renal disease in Gitelman's syndrome) as well as the first report of the use of peritoneal dialysis in either Bartter's syndrome or Gitelman's syndrome. The clinical course highlights the importance of and the need for careful control of hemodynamic status in these patients to slow the progression of renal injury. The hemodynamic alterations that characterize Bartter's syndrome and Gitelman's syndrome patients suggest that for patients requiring renal replacement therapy, peritoneal dialysis is a more appropriate treatment because of its less severe impact on these parameters.
authors: Department of Clinical and Experimental Medicine, Clinica Medica 4, Division of Nephrology, University of Padova, Italy.
authors: L
authors: L
authors: Bonfante
authors: P A
authors: PA
authors: Davis
authors: M
authors: M
authors: Spinello
authors: A
authors: A
authors: Antonello
authors: A
authors: A
authors: D'Angelo
authors: A
authors: A
authors: Semplicini
authors: L
authors: L
authors: Calò
mesh_terms: D000328:Adult; D001477:Bartter Syndrome / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D002352:Carrier Proteins / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D009154:Mutation; D010530:Peritoneal Dialysis; D011189:Potassium Chloride / Q000627:therapeutic use; D011955:Receptors, Drug / Q000235:genetics; D049992:Sodium Chloride Symporters; D064486:Solute Carrier Family 12, Member 3; D027981:Symporters; D013577:Syndrome
chemical_list: D002352:Carrier Proteins; D011955:Receptors, Drug; C578874:SLC12A3 protein, human; D049992:Sodium Chloride Symporters; D064486:Solute Carrier Family 12, Member 3; D027981:Symporters; C064415:thiazide receptor; D011189:Potassium Chloride